PubRank
Search
About
A Global Study to Assess the Effects of MEDI4736, Given as Monotherapy or in Combination With Tremelimumab Determined by PD-L1 Expression Versus Standard of Care in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer (ARCTIC)
Clinical Trial ID NCT02352948
PubWeight™ 11.95
‹?›
🔗 Visit the ClinicalTrials.gov page for NCT02352948
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Antibodies to watch in 2016.
MAbs
2015
1.17
2
Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy.
J Hematol Oncol
2016
1.12
3
Cytotoxic T lymphocyte antigen-4 and immune checkpoint blockade.
J Clin Invest
2015
0.98
4
Checkpoint inhibitors in lung cancer: latest developments and clinical potential.
Ther Adv Med Oncol
2016
0.96
5
Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical Applications.
Front Immunol
2015
0.92
6
Current progress in immunotherapy for pancreatic cancer.
Cancer Lett
2015
0.83
7
Novel cancer antigens for personalized immunotherapies: latest evidence and clinical potential.
Ther Adv Med Oncol
2016
0.81
8
Programmed cell death protein-1/programmed cell death ligand-1 pathway inhibition and predictive biomarkers: understanding transforming growth factor-beta role.
Transl Lung Cancer Res
2015
0.80
9
PD-1/PD-L1 blockades in non-small-cell lung cancer therapy.
Onco Targets Ther
2016
0.78
10
Trends and advances in tumor immunology and lung cancer immunotherapy.
J Exp Clin Cancer Res
2016
0.78
11
Immunotherapy in non-small cell lung cancer: the clinical impact of immune response and targeting.
Ann Transl Med
2016
0.77
12
Immunotherapy for non-small cell lung cancer: current concepts and clinical trials.
Eur J Cardiothorac Surg
2015
0.77
13
Lung cancer in 2015: Bypassing checkpoints, overcoming resistance, and honing in on new targets.
Nat Rev Clin Oncol
2015
0.76
14
Immune checkpoint inhibitors: the new frontier in non-small-cell lung cancer treatment.
Onco Targets Ther
2016
0.75
Next 100